Sort   by:  
 Page size 
Intellance-2: TruSight Tumor 170 panel based DNA-seq
Intellance-2: TruSight Tumor 170 panel based RNA-seq
This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (...
Whole transcriptome sequencing (RNAseq) of 14 cases with suspected primary eosinophilia was performed to identify recurrent mutations which could be used as new diagnostic and prognostic markers as well as potential targets for therapy.
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size